19 June 2013
Keywords: glivec, gets, chmp, nod, new, indication, swiss
Article | 30 March 2009
Swiss drug major Novartis has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 2009
18 June 2013
© 2013 thepharmaletter.com